Pro Dex Inc (PDEX) stock

PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/306% below fair value

$65.66−1.76 (-2.61%)

Close on Nov 13, 2026Market cap $210.11MP/E 18.1Yield –

Earnings

Pro Dex's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Jan 28, 2027

Q2 FY2027 · estimated, after the close

Revenue, Q1 FY2027

$20.60M

+11.4% on a year earlier

EPS, Q1 FY2027

$0.92

$1.40 a year earlier

Latest guidance

None

No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Pro Dex's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Source
Q2 FY2027ended Dec 31, 2026	Jan 28, 2027Expected	–	–	–	–
Q1 FY2027ended Sep 30, 2026	Oct 29, 2026after the close	$20.60M	+11.4%	$0.92	Release
Q4 FY2026ended Jun 30, 2026	Sep 3, 2026after the close	$20.40M	+16.6%	$0.87	Release
Q3 FY2026ended Mar 31, 2026	Apr 30, 2026after the close	$19.90M	+14.4%	$1.20	Release
Q2 FY2026ended Dec 31, 2025	Jan 29, 2026after the close	$18.70M	+11.3%	$0.66	Release
Q1 FY2026ended Sep 30, 2025	Oct 30, 2025after the close	$18.50M	+24.2%	$1.40	Release
Q4 FY2025ended Jun 30, 2025	Sep 4, 2025after the close	$17.50M	+16.7%	$0.36	Release
Q3 FY2025ended Mar 31, 2025	May 1, 2025after the close	$17.40M	+21.7%	$0.98	Release
Q2 FY2025ended Dec 31, 2024	Jan 30, 2025after the close	$16.80M	+33.3%	$0.61	Release
Q1 FY2025ended Sep 30, 2024	Oct 31, 2024after the close	$14.90M	+40.6%	$0.75	Release
Q4 FY2024ended Jun 30, 2024	Sep 5, 2024after the close	$15.00M	–	$0.46	Release
Q3 FY2024ended Mar 31, 2024	May 2, 2024after the close	$14.30M	+9.2%	$0.19	Release
Q2 FY2024ended Dec 31, 2023	Feb 8, 2024after the close	$12.60M	+11.5%	$0.14	Release
Q1 FY2024ended Sep 30, 2023	Oct 13, 2023after the close	$10.60M	-4.5%	$0.42	Release
Q3 FY2023ended Mar 31, 2023	May 4, 2023after the close	$13.10M	+40.9%	$0.36	Release
Q2 FY2023ended Dec 31, 2022	Feb 2, 2023after the close	$11.30M	+10.8%	$0.24	Release
Q1 FY2023ended Sep 30, 2022	Nov 3, 2022after the close	$11.10M	+11.0%	$0.29	Release
Q4 FY2022ended Jun 30, 2022	Aug 25, 2022after the close	$12.60M	–	$0.38	Release
Q3 FY2022ended Mar 31, 2022	May 5, 2022after the close	$9.30M	–	$0.12	Release
Q2 FY2022ended Dec 31, 2021	Feb 3, 2022after the close	$10.20M	–	$0.25	Release
Q1 FY2022ended Sep 30, 2021	Nov 15, 2021after the close	$10.00M	–	$0.28	Release
Q4 FY2021ended Jun 30, 2021	Aug 26, 2021after the close	–	–	–	Filing
Q3 FY2021ended Mar 31, 2021	May 6, 2021after the close	–	–	–	Filing
Q2 FY2021ended Dec 31, 2020	Feb 4, 2021after the close	–	–	–	Filing
Q1 FY2021ended Sep 30, 2020	Nov 5, 2020after the close	–	–	–	Filing
Q4 FY2020ended Jun 30, 2020	Aug 27, 2020after the close	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Pro Dex has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Pro Dex puts a forecast in an earnings release, it is listed here with the exact sentence.